A detailed history of Probity Advisors, Inc. transactions in Illumina, Inc. stock. As of the latest transaction made, Probity Advisors, Inc. holds 1,830 shares of ILMN stock, worth $248,916. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,830
Holding current value
$248,916
% of portfolio
0.05%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$105.28 - $135.9 $192,662 - $248,697
1,830 New
1,830 $238,000
Q1 2024

May 02, 2024

SELL
$127.73 - $147.2 $14,688 - $16,928
-115 Reduced 7.01%
1,525 $209,000
Q4 2023

Feb 12, 2024

SELL
$92.79 - $142.53 $36,744 - $56,441
-396 Reduced 19.45%
1,640 $228,000
Q3 2023

Nov 14, 2023

SELL
$128.91 - $192.44 $9,539 - $14,240
-74 Reduced 3.51%
2,036 $279,000
Q2 2023

Aug 10, 2023

BUY
$183.43 - $232.67 $18,526 - $23,499
101 Added 5.03%
2,110 $395,000
Q4 2022

Feb 14, 2023

BUY
$187.24 - $242.74 $70,963 - $91,998
379 Added 23.25%
2,009 $406,000
Q3 2022

Nov 14, 2022

SELL
$177.23 - $227.44 $6,025 - $7,732
-34 Reduced 2.04%
1,630 $311,000
Q2 2022

Aug 12, 2022

BUY
$181.58 - $368.0 $4,357 - $8,832
24 Added 1.46%
1,664 $307,000
Q1 2022

May 10, 2022

BUY
$303.87 - $423.8 $13,370 - $18,647
44 Added 2.76%
1,640 $573,000
Q4 2021

Feb 10, 2022

SELL
$347.28 - $421.83 $3,472 - $4,218
-10 Reduced 0.62%
1,596 $607,000
Q3 2021

Oct 08, 2021

SELL
$405.61 - $524.84 $8,112 - $10,496
-20 Reduced 1.23%
1,606 $651,000
Q2 2021

Aug 06, 2021

BUY
$372.84 - $481.5 $4,474 - $5,778
12 Added 0.74%
1,626 $769,000
Q1 2021

Apr 28, 2021

SELL
$361.28 - $504.76 $4,335 - $6,057
-12 Reduced 0.74%
1,614 $620,000
Q3 2020

Nov 09, 2020

BUY
$268.51 - $400.74 $805 - $1,202
3 Added 0.18%
1,626 $503,000
Q2 2020

Aug 03, 2020

SELL
$256.46 - $373.01 $3,590 - $5,222
-14 Reduced 0.86%
1,623 $601,000
Q1 2020

May 15, 2020

BUY
$209.2 - $335.53 $22,384 - $35,901
107 Added 6.99%
1,637 $447,000
Q4 2019

Feb 13, 2020

BUY
$288.29 - $335.49 $33,153 - $38,581
115 Added 8.13%
1,530 $508,000
Q3 2019

Nov 14, 2019

BUY
$266.84 - $378.23 $12,007 - $17,020
45 Added 3.28%
1,415 $430,000
Q2 2019

Aug 08, 2019

SELL
$300.59 - $368.15 $6,913 - $8,467
-23 Reduced 1.65%
1,370 $504,000
Q1 2019

Apr 29, 2019

BUY
$272.57 - $321.18 $33,798 - $39,826
124 Added 9.77%
1,393 $433,000
Q4 2018

Feb 12, 2019

SELL
$272.46 - $366.54 $817 - $1,099
-3 Reduced 0.24%
1,269 $381,000
Q3 2018

Nov 14, 2018

SELL
$279.04 - $367.06 $1,395 - $1,835
-5 Reduced 0.39%
1,272 $467,000
Q2 2018

Aug 13, 2018

SELL
$228.17 - $292.07 $1,825 - $2,336
-8 Reduced 0.62%
1,277 $357,000
Q4 2017

Feb 09, 2018

BUY
$202.23 - $230.03 $18,402 - $20,932
91 Added 7.62%
1,285 $281,000
Q3 2017

Oct 27, 2017

BUY
$172.3 - $213.93 $205,726 - $255,432
1,194
1,194 $238,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Probity Advisors, Inc. Portfolio

Follow Probity Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Probity Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Probity Advisors, Inc. with notifications on news.